Anti-IGFBP1 Antibody

Raised in rabbit against the IGFBP1 target, this unconjugated polyclonal antibody from Antibodies.com is validated for Western blot and ELISA workflows. IGFBP1, an IGF-binding protein synthesized primarily in the liver, modulates IGF-1 and IGF-2 bioavailability and is widely studied in metabolic, reproductive, and oncology research contexts, where it frequently serves as a marker of hepatic and placental activity. The reagent is supplied at a volume of 100 µl, carries no conjugated label so it can be paired with a secondary detection reagent of choice, and is reactive with human samples. Researchers commonly apply it to characterize expression patterns in tissue lysates, supporting studies on glucose homeostasis, trophoblast biology, and tumor microenvironments. The polyclonal format provides recognition of multiple epitopes on the IGFBP1 protein, which can be useful when working with post-translationally modified or partially degraded targets where monoclonal reagents may not bind effectively.